Since healthy cells are not heavily dependent on aberrantly increased HDAC activity like malignant cells are, they are significantly resistant to HDAC inhibitors-induced cell death, whereas differentiated and cancer cells are sensitive to HDAC inhibitors [3,14]. The gene discussed is HDAC9; the disease is cancer.